COVID-19 and Influenza to be Initial Focus of Google Health Studies App
Google is upping its focus on health research with a new mobile app that lets smartphone users participate in virtual [...]
Trump’s Last Ditch Effort to Change Rx Price Rules
The Trump administration’s 11th hour attempt to bring down high prescription drug costs succeeded in drawing swift condemnation from health [...]
What’s Driving Oncology HTAs in South Korea?
Reimbursement in South Korea depends upon a favorable review by Health Insurance Review Agency (HIRA), and some therapies may not [...]
Google Launches Health Studies App
Google made a major move into health research on Wednesday, unveiling a new smartphone app that lets Android users participate [...]
Outrage Over Google’s Firing of AI Ethicist Timnit Gebru
Google abruptly fired Timnit Gebru last night, an AI ethicist who has tremendous respect around the world for her work [...]
Reshaping of Global Policy by COVID: Implications for Market Access
The COVID-19 pandemic has upended daily lives around the globe and has also created new challenges for life sciences companies [...]
Virtual ISPOR 2021 Issue Panel & Workshop Proposals Due Next Week!
Submit by Wednesday, December 16 for an Opportunity to Present Your Research at Virtual ISPOR 2021! Due to the constraints [...]
Delays in Clinical Trials Present Pharma Companies With Opportunities to Evolve
COVID-19 has upended clinical trial timelines – putting billions of forecasted sales at risk and delaying getting life-saving treatments to [...]
[Webinar] Tumor Profiling for Health Insurance Providers
On December 10, 2020 1:00 PM – 2:00 PM ET, Illumina will host a webinar on comprehensive genomic profiling (CGP). [...]
Using Real World Data to Close the Rare Disease Gap
7,000. That’s the estimated number of distinct types of rare and genetic diseases affecting more than 400 million people around [...]
[Webinar] Setting the Agenda for #46
On December 9, 4pm CST, Optum will host a webinar focusing on healthcare-related issues that will be in the forefront [...]
Data on a Mission: Removing Barriers to Understanding of Rare Disease
Research and drug development for rare and genetic diseases is challenging without insight into history and clinical manifestations. Missing efficacy [...]
Healthcare Artificial Intelligence Market: Global Forecast to 2027
Report Highlights: The global healthcare artificial intelligence (AI) market is expected to grow at a CAGR of 41.4% from 2020 [...]
Six Payer Executives to Watch in 2021
The past year has forced health plans to nimbly adapt to the demands of a global pandemic, including massive spikes [...]
Improving Peer Review in Economics
Three experimental economists, Gary Charness (UCSB), Anna Dreber (SSE) and Severine Toussaert (Oxford), are conducting a 15-20 min anonymous survey [...]
Response to NICE Methods of Health Technology Evaluation
NICE recently posted a consultation entitled "The NICE methods of health technology evaluation: the case for change". which detailed its [...]
New Healthcare Venture from Uber Health’s Dan Trigub
Trigub and co-founder Inna Plumb have launched MedArrive as a new care management platform that enables healthcare providers and payers [...]
ICER Analytics™ Accelerates Real-World Application of ICER Reports
The Institute for Clinical and Economic Review (ICER) today formally launched ICER Analytics™, a new cloud-based platform that will revolutionize the [...]
Disruption and Transformation in the COVID Era: 5 Pharma Trends for 2021
The prospective pharmaceutical industry trends first identified by Tribeca Knowledge in late 2019 were all pre-COVID, even though they continue to unfold. [...]
AMCP Nexus 2020: The Specialty Pharmacy Pipeline
The specialty pharmaceutical market is continuing to see increased competition, and in the past 10 years, there has been a [...]
Innovative Payments, Management are Needed for Cell and Gene Therapies
Cell and gene therapies are a transformative approach that provides new therapeutic options for patients with cancer, immune disorders, hemophilia, [...]
MMIT Partners With Leading Patient Access Hubs
Understanding market access is hard. Tracking shifts in coverage and payer policies for pharmaceutical products is even harder. MMIT partners [...]
Is Real-World Evidence Used in P&T Monographs and Therapeutic Class Reviews?
Little is known about when and what types of real-world evidence (RWE) studies inform pharmacy and therapeutic (P&T) committee decisions. [...]
CMS Announces Drug Payment Reductions with the “Most Favored Nation” Effective January 1, 2021
Centers for Medicare and Medicaid Services (CMS) announced the long-awaited seven year Most Favored Nation (MFN) model as an interim [...]
Reimbursing Innovative and Potentially Curative Gene and Cell Therapies
In this feature, following his participation in a workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific [...]